Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)
CNY 19.6
(0.56%)
CNY 19.6
(0.56%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 254.72 Million CNY | -9.31% |
| 2022 | 280.87 Million CNY | 35.59% |
| 2021 | 207.15 Million CNY | 30.36% |
| 2020 | 158.9 Million CNY | 24.36% |
| 2019 | 127.77 Million CNY | 15.84% |
| 2018 | 110.3 Million CNY | 21.43% |
| 2017 | 90.83 Million CNY | 27.92% |
| 2016 | 71.01 Million CNY | 23.51% |
| 2015 | 57.49 Million CNY | -13.47% |
| 2014 | 66.44 Million CNY | 26.2% |
| 2013 | 52.65 Million CNY | 70.78% |
| 2012 | 30.83 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 7.27 Million CNY | -90.52% |
| 2024 Q1 | 76.69 Million CNY | -34.35% |
| 2024 Q3 | 18.17 Million CNY | 149.83% |
| 2023 Q4 | 116.82 Million CNY | 135.29% |
| 2023 Q3 | 49.65 Million CNY | 78.35% |
| 2023 FY | 254.72 Million CNY | -9.31% |
| 2023 Q1 | 60.4 Million CNY | -59.51% |
| 2023 Q2 | 27.84 Million CNY | -53.91% |
| 2022 Q4 | 149.19 Million CNY | 205.63% |
| 2022 Q2 | 23.66 Million CNY | -60.04% |
| 2022 Q1 | 59.21 Million CNY | -49.19% |
| 2022 FY | 280.87 Million CNY | 35.59% |
| 2022 Q3 | 48.81 Million CNY | 106.3% |
| 2021 Q3 | 34.21 Million CNY | 127.34% |
| 2021 Q4 | 116.54 Million CNY | 240.65% |
| 2021 Q1 | 41.34 Million CNY | -53.07% |
| 2021 Q2 | 15.04 Million CNY | -63.61% |
| 2021 FY | 207.15 Million CNY | 30.36% |
| 2020 Q2 | 9.43 Million CNY | -72.14% |
| 2020 Q3 | 27.51 Million CNY | 191.77% |
| 2020 FY | 158.9 Million CNY | 24.36% |
| 2020 Q4 | 88.1 Million CNY | 220.23% |
| 2020 Q1 | 33.84 Million CNY | -50.66% |
| 2019 Q3 | 11.04 Million CNY | 135.19% |
| 2019 FY | 127.77 Million CNY | 15.84% |
| 2019 Q4 | 68.6 Million CNY | 521.37% |
| 2019 Q2 | 4.69 Million CNY | -89.19% |
| 2019 Q1 | 43.43 Million CNY | -9.69% |
| 2018 Q1 | 36.06 Million CNY | -10.94% |
| 2018 FY | 110.3 Million CNY | 21.43% |
| 2018 Q4 | 48.09 Million CNY | 487.68% |
| 2018 Q3 | 8.18 Million CNY | -54.43% |
| 2018 Q2 | 17.96 Million CNY | -50.2% |
| 2017 FY | 90.83 Million CNY | 27.92% |
| 2017 Q1 | 23.82 Million CNY | -34.6% |
| 2017 Q2 | 17.12 Million CNY | -28.12% |
| 2017 Q3 | 9.4 Million CNY | -45.07% |
| 2017 Q4 | 40.48 Million CNY | 330.49% |
| 2016 Q1 | 19.61 Million CNY | 0.0% |
| 2016 Q4 | 36.42 Million CNY | 707.43% |
| 2016 FY | 71.01 Million CNY | 23.51% |
| 2016 Q3 | 4.51 Million CNY | -56.87% |
| 2016 Q2 | 10.46 Million CNY | -46.68% |
| 2015 FY | 57.49 Million CNY | -13.47% |
| 2014 FY | 66.44 Million CNY | 26.2% |
| 2013 FY | 52.65 Million CNY | 70.78% |
| 2012 FY | 30.83 Million CNY | 0.0% |